Articles From: - Texas Capital Bancshares, Inc. Announces Q4 2014 Earnings Call to - OmniVision and Wavelens Bring MEMS-Based High-Speed Autofocus to Next-Generation Smartphones


The 13D Activist Fund (DDDIX), the first mutual fund to offer investors pure exposure to shareholder activism, has achieved a market-beating three-year track record.
Sign-up for - You Do Not Need to Be a Hedge Fund Investor to Have Made Money in Activism investment picks
Leading technology media company TechTarget, Inc. (NASDAQ: TTGT) today announced IT Deal Alert Priority Engine TM for Inside Sales and Marketing and Deal Data TM for Data Scientists, two new project intelligence services to help sales, marketing, and data science teams to identify new prospects, prioritize accounts and provide more intelligence in real-time.
Sign-up for - TechTarget Launches IT Deal AlertTM Priority Engine and Deal Data to Deliver Next Generation IT Project Intelligence for Sales and Marketing Teams investment picks
2015/1/8
Clinic to offer access to medical care for low income residents in need HOUSTON , Jan.
Sign-up for 2015/1/8 - Tara Energy Proudly Supports Latest Opening of Ibn Sina Foundation's Community Health Clinic in Houston investment picks
2015/1/8
Allied World Assurance Company Holdings, AG announced today the commencement of its in-house trade credit and political risk insurance platform with the completion of its previously-announced acquisition of its former program administrator, Latin American Underwriters Holdings Ltd.
Sign-up for 2015/1/8 - Allied World Announces In-House Trade Credit Insurance Platform; Completes Acquisition of Latin American Underwriters Holdings Ltd. investment picks
2015/1/8
By Elizabeth O'Brien, MarketWatch They say the best exercise program is any one that you can stick with.
Sign-up for 2015/1/8 - UPDATE: 3 health resolutions you can actually keep in 2015 investment picks
2015/1/8
Call it the ultimate tax break.
Sign-up for 2015/1/8 - TurboTax Absolute Zero: The No-cost Tax Return investment picks
By Andria Cheng, MarketWatch NEW YORK (MarketWatch) -- Analysts said that Santa delivered for retailers this holiday shopping season -- but it may only seem that way because concerns about heavy discounting and declining mall traffic weighed on expectations going into the season.
Sign-up for - UPDATE: Retailers' 'strong' sales figures exaggerated by low expectations investment picks
Vishay Intertechnology, Inc. (NYSE: VSH) today announced that the company has been recognized by the SPDEI, the French association of distributors of electronic components, as a top supplier of 2014.
Sign-up for - Vishay Intertechnology Honored by SPDEI, the French Association of Distributors of Electronic Components, in Passive Components Category investment picks
2015/01/08
There were many surprises in 2014's bond markets, but a few managers got it right.
Sign-up for 2015/01/08 - Nominees for 2014 Fixed-Income Fund Manager of the Year investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1168090&ProfileId=051205&sourceType=1 SAN DIEGO, CA --
Sign-up for - Regen BioPharma Inc. Identifies Second Generation Gene Silencing Candidates for Blocking Cancer Stem Cell Gene Target investment picks
Pacira Pharmaceuticals, Inc. (NASDAQ: PCRX) today announced that it has scheduled an Analyst & Investor Day on Thursday, Jan.
Sign-up for - Pacira Pharmaceuticals, Inc. to Host Analyst & Investor Day on Jan. 22 in New York investment picks
2015/1/8
By David Benoit and Jacob Bunge Nelson Peltz's investment firm launched a fight against DuPont Co.
Sign-up for 2015/1/8 - Trian Seeks Four Seats on DuPont's Board--2nd update investment picks
Phase 3 program aims to address patient need for alternative treatment options in moderate-to-severe psoriasis   Program includes the first Phase 3 study in psoriasis comparing two anti-TNFs   Based on current enrollment projections, top-line data from these studies are expected in 2017 MENLO PARK, Calif., and BRUSSELS, Belgium, Jan.
Sign-up for - Dermira and UCB Announce Start of Phase 3 Program for CIMZIA(R) (certolizumab pegol) in Psoriasis investment picks
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced that ASPIRA, a Phase 2 study of duvelisib, an oral inhibitor of phosphoinositide-3-kinase (PI3K)-delta and PI3K-gamma, with background methotrexate in patients with moderate-to-severe rheumatoid arthritis (RA) did not meet its primary endpoint.
Sign-up for - Infinity Reports Topline Results from Phase 2 Study of Duvelisib in Rheumatoid Arthritis investment picks
Total revenue in the range of $72 to $74 million, up 20% to 24% y/y (pro-forma excluding Syneron Beauty), including approximately 50% product revenue growth in North America Strong UltraShape full commercial launch in U.S. with more than 50 systems sold Successful global launch of PicoWay with approximately $2.5 million in sales from mid-November through the end of the year YOKNEAM, Israel , Jan.
Sign-up for - Syneron Medical Announces Preliminary Fourth Quarter 2014 Revenue investment picks
Teva Pharmaceutical Industries Ltd.
Sign-up for - Teva to Present at the 33rd Annual J.P. Morgan Healthcare Conference investment picks
2015/1/8
By Neil Maclucas ZURICH--Novartis AG (NOVN.VX) said it has filed for U.S. regulatory approval of two drugs that treat chronic lung diseases after late-stage clinical tests demonstrated the treatments met their primary goals.
Sign-up for 2015/1/8 - Novartis Applies for U.S. Approval for Lung Disease Drugs investment picks
UK Trade Union Among the First of Reliable Networks' Customers to Select CYREN Cybersecurity Solutions MCLEAN, Va.
Sign-up for - Reliable Networks Signs High Profile Customer After Joining VCW's Channel Network for CYREN WebSecurity investment picks
Illumina, Inc. (NASDAQ: ILMN) today announced that the African Orphan Crops Consortium (AOCC) is the 2015 recipient of the Agricultural Greater Good Initiative grant.
Sign-up for - Illumina Announces African Orphan Crops Consortium to Receive Agricultural Greater Good Initiative Grant investment picks
mRNA Delivery a Natural Fit for ZFN-mediated Genome Editing Which Requires Only Transient Expression to Achieve a Permanent Therapeutic Effect RICHMOND, Calif.
Sign-up for - Sangamo BioSciences Announces In-Licensing Of mRNA Delivery Technology And Expansion Of Therapeutic Pipeline Opportunities For Sangamo's In Vivo ZFN Genome-Editing Platform investment picks
Antares Pharma, Inc. (NASDAQ: ATRS) today announced that Eamonn P.
Sign-up for - Antares Pharma to Present at the 33rd Annual J.P. Morgan Healthcare Conference investment picks
http://media.marketwire.com/attachments/201203/26852_oceanrig.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1168119&ProfileId=051205&sourceType=1 NICOSIA, CYPRUS --
Sign-up for - Ocean Rig UDW Inc. Announces Agreement With ENI and Fleet Employment Update investment picks
Aradigm Corporation (Nasdaq:ARDM) (the "Company") today announced that President and Chief Executive Officer, Igor Gonda, Ph.D., will present an overview of the Company at Biotech Showcase 2015 on Wednesday, January 14, 2015, at 2:30 p.m. Pacific time.
Sign-up for - Aradigm to Present at Biotech Showcase 2015 on January 14 investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G029856-001&sourceType=1 http://www.marketwire.com/library/MwGo/2015/1/7/11G029856/Logo1-418189463.jpg FORT LAUDERDALE, FL--(Marketwired - January 08, 2015) - BBX Capital Corporation ("BBX Capital" and/or the "Company") (NYSE: BBX), today announced that its Board of Directors has approved the appointment of Raymond S.
Sign-up for - BBX Capital Corporation Approves the Appointment of Raymond S. Lopez as Chief Financial Officer investment picks
Biogen Idec's (BIIB) stock was up 6.2% after the company reported Thursday that a treatment for acute optic neuritis it has developed proved to be effective in the second phase of a research study.
Sign-up for - Biogen rises 6.2% after strong study results investment picks
2015/1/8
By Angela Chen Global Payments Inc. said its revenue rose 10% in the November-ended quarter as the electronics-payments company continues to look at possible acquisitions and expand into the Asian market.
Sign-up for 2015/1/8 - Global Payments Profit, Revenue Rise investment picks
2015/1/8
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G029802-001&sourceType=1 http://www.marketwire.com/library/MwGo/2015/1/7/11G029802/Scotiabank-logo-780364326799.jpg TORONTO, ON--(Marketwired - January 08, 2015) - Scotiabank's President and Chief Executive Officer Brian Porter will take part in a question-and-answer session at the RBC Capital Markets Canadian Bank CEO Conference in Toronto on January 14, 2015.
Sign-up for 2015/1/8 - Scotiabank's President and CEO Brian Porter to Speak at RBC Capital Markets Conference investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: - Texas Capital Bancshares, Inc. Announces Q4 2014 Earnings Call to - OmniVision and Wavelens Bring MEMS-Based High-Speed Autofocus to Next-Generation Smartphones
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent